Investigational venetoclax combination therapy in acute myeloid leukemia - a systematic review and meta-analysis

被引：2
|
作者：
Shimony, Shai [1 ,2 ,3 ]
Rozental, Alon [2 ,3 ]
Bewersdorf, Jan P. [4 ]
Goldberg, Aaron D. [4 ]
Stein, Eytan M. [4 ]
Grimshaw, Alyssa A. [5 ]
Stone, Richard M. [1 ]
DeAngelo, Daniel J. [1 ]
Wolach, Ofir [2 ,3 ]
Stahl, Maximilian [1 ]
机构：
[1] Dana Farber Canc Inst, Med Oncol, Boston, MA 02215 USA
[2] Rabin Med Ctr, Petah Tiqwa, Israel
[3] Sackler Med Sch, Tel Aviv, Israel
[4] Mem Sloan Kettering Canc Ctr, Leukemia Serv, New York, NY USA
[5] Yale Univ, Harvey Cushing John Hay Whitney Med Lib, New Haven, CT USA
来源：
HAEMATOLOGICA | 2022年 / 107卷 / 12期
关键词：
CARE;
D O I：
10.3324/haematol.2022.281453
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2955 / 2960
页数：6
相关论文
共 50 条
  • [1] Efficacy and safety of venetoclax combination therapy for relapsed/refractory acute myeloid leukemia: a systematic review and meta-analysis
    Jiao, Ning
    Shi, Lina
    Wang, Shaohua
    Sun, Yonghao
    Bai, Yujun
    Zhang, Dengshan
    BMC CANCER, 2024, 24 (01)
  • [2] Venetoclax and azacitidine for acute myeloid leukemia patients: a systematic review and meta-analysis
    Noersamsjah, A. M.
    Lim, Y.
    Chandra, A. I.
    Kurniawan, A.
    ANNALS OF ONCOLOGY, 2024, 35 : S1368 - S1368
  • [3] Meta-analysis of the efficacy of venetoclax and azacitidine combination therapy and azacitidine monotherapy for treating acute myeloid leukemia
    Xie, Yuqin
    Wei, Xueqin
    Wang, Weiwei
    Liao, Changsheng
    Han, Pengfei
    Yu, Yanhui
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2024, 27 (04)
  • [4] The efficacy and safety of venetoclax and azacytidine combination treatment in patients with acute myeloid leukemia and myelodysplastic syndrome: systematic review and meta-analysis
    Du, Yufeng
    Li, Chunhong
    Yan, Jinsong
    HEMATOLOGY, 2023, 28 (01)
  • [5] Venetoclax combined chemotherapy versus chemotherapy alone for acute myeloid leukemia: a systematic review and meta-analysis
    Zhu, Jingkui
    Fan, Jixin
    Xie, Tiantian
    Zhao, Haiqiu
    Lu, Runqing
    Zhang, Yinyin
    Li, Yingmei
    Xie, Xinsheng
    Wan, Dingming
    Jiang, Zhongxing
    He, Fei
    Guo, Rong
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [6] Venetoclax and azacitidine compared with azacitidine monotherapy for acute myeloid leukemia patients: A systematic review and meta-analysis
    Noersamsjah, A. M.
    Lim, Y.
    Chandra, A. I.
    Kurniawan, A.
    ANNALS OF ONCOLOGY, 2023, 34 : S1603 - S1604
  • [7] Efficacy and safety of venetoclax-based combination therapy for previously untreated acute myeloid leukemia: a meta-analysis
    He, Hongbo
    Wen, Xiaojia
    Zheng, Huyong
    HEMATOLOGY, 2024, 29 (01)
  • [8] The efficacy and adverse events of venetoclax in combination with hypomethylating agents treatment for patients with acute myeloid leukemia and myelodysplastic syndrome: a systematic review and meta-analysis
    Liu, Bei
    Guo, Yuancheng
    Deng, Lijuan
    Qiao, Yanhong
    Jian, Jinli
    HEMATOLOGY, 2020, 25 (01) : 414 - 423
  • [9] Venetoclax as monotherapy and in combination with hypomethylating agents or low dose cytarabine in relapsed and treatment refractory acute myeloid leukemia: a systematic review and meta-analysis
    Bewersdorf, Jan Philipp
    Giri, Smith
    Wang, Rong
    Williams, Robert T.
    Tallman, Martin S.
    Zeidan, Amer M.
    Stahl, Maximilian
    HAEMATOLOGICA, 2020, 105 (11) : 2659 - 2663
  • [10] Acute myeloid leukemia during pregnancy: a systematic review and meta-analysis
    Horowitz, Netanel A.
    Henig, Israel
    Henig, Oryan
    Benyamini, Noam
    Vidal, Liat
    Avivi, Irit
    LEUKEMIA & LYMPHOMA, 2018, 59 (03) : 610 - 616
12345